Maternal Immune Response and Neonatal Seroprotection from a Single Dose of a Monovalent Nonadjuvanted 2009 influenza A(H1N1) vaccine: A single-group trial

Annals of Internal Medicine

Volumn 155, Issue 11, 2011, Pages 733-741

  Tsatsaris, Vassilis ^a   Capitant, Catherine ^b   Schmitz, Thomas ^c   Chazallon, Corine ^b   Bulifon, Sophie ^a   Riethmuller, Didier ^d   Picone, Olivier ^e   Poulain, Patrice ^f   Lewin, Fanny ^a   Lainé, Fabrice ^g   Jacqz Aigrain, Evelyne ^c   Aboulker, Jean Pierre ^b   Launay, Odile ^a  

^a université Paris Cité   (France)

^b INSERM   (France)

^c HÔPITAL ROBERT DEBRÉ   (France)

^d UNIVERSITY HOSPITAL OF BESANÇON   (France)

^e HÔPITAL ANTOINE BÉCLÈRE   (France)

^f SERVICE DE RHUMATOLOGIE   (France)

^g PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE; INFLUENZA VIRUS HEMAGGLUTININ; NONADJUVANTED 2009 H1N1 INFLUENZA VACCINE; UNCLASSIFIED DRUG; VIRUS ANTIBODY;

2009 H1N1 INFLUENZA; ADULT; ANTIBODY TITER; ARTHRALGIA; ARTICLE; ASTHENIA; CHILL; CLINICAL TRIAL; CORD SERUM; DELIVERY; DRUG INDUCED HEADACHE; FEMALE; FEVER; FRANCE; HEMAGGLUTINATION INHIBITION; HUMAN; HYPERHIDROSIS; IMMUNE RESPONSE; IMMUNOGENICITY; INJECTION SITE ERYTHEMA; INJECTION SITE INDURATION; INJECTION SITE PAIN; MULTICENTER STUDY; MYALGIA; NEWBORN; PASSIVE IMMUNIZATION; PHASE 2 CLINICAL TRIAL; PREGNANCY; PRIORITY JOURNAL; SECOND TRIMESTER PREGNANCY; SEROCONVERSION; THIRD TRIMESTER PREGNANCY;

EID: 82855167199     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/0003-4819-155-11-201112060-00005     Document Type: Article

References (31)

1. Mak TK, Mangtani P, Leese J, Watson JM, Pfeifer D. Influenza vaccination in pregnancy: current evidence and selected national policies. Lancet Infect Dis. 2008;8:44-52. [PMID: 18156088]
2. Cox S, Posner SF, McPheeters M, Jamieson DJ, Kourtis AP, Meikle S. Hospitalizations with respiratory illness among pregnant women during influenza season. Obstet Gynecol. 2006;107:1315-22. [PMID: 16738158]
3. Neuzil KM, Reed GW, Mitchel EF, Simonsen L, Griffin MR. Impact of influenza on acute cardiopulmonary hospitalizations in pregnant women. Am J Epidemiol. 1998;148:1094-102. [PMID: 9850132]
4. Englund JA. Maternal immunization with inactivated influenza vaccine: rationale and experience. Vaccine. 2003;21:3460-4. [PMID: 12850360]
5. Black SB, Shinefield HR, France EK, Fireman BH, Platt ST, Shay D; Vaccine Safety Datalink Workgroup. Effectiveness of influenza vaccine during pregnancy in preventing hospitalizations and outpatient visits for respiratory illness in pregnant women and their infants. Am J Perinatol. 2004;21:333-9. [PMID: 15311370]
6. Zaman K, Roy E, Arifeen SE, Rahman M, Raqib R, Wilson E, et al. Effectiveness of maternal influenza immunization in mothers and infants. N Engl J Med. 2008;359:1555-64. [PMID: 18799552]
7. Influenza vaccines. Wkly Epidemiol Rec. 2005;80:279-87. [PMID: 16171031]
8. Mereckiene J, Cotter S, Nicoll A, Levy-Bruhl D, Ferro A, Tridente G, et al; VENICE Project Gatekeepers Group. National seasonal influenza vaccination survey in Europe, 2008. Euro Surveill. 2008;13. [PMID: 18947524]
9. Haut Conseil de la Sante Publique. Avis Relatifála Vaccination Contre la Grippe Saisonniére de L'enfant et de la Femme Enceinte. Paris: Haut Conseil de la Sante ́ Publique; 2008. Accessed at www.hcsp.fr/docspdf/avisrapports /hcspa20080201_Grippe.pdf on 6 October 2011
10. Zarocostas J. World Health Organization declares A (H1N1) influenza pandemic. BMJ. 2009;338:b2425. [PMID: 19525308]
11. Jamieson DJ, Honein MA, Rasmussen SA, Williams JL, Swerdlow DL, Biggerstaff MS, et al; Novel Influenza A (H1N1) Pregnancy Working Group. H1N1 2009 influenza virus infection during pregnancy in the USA. Lancet. 2009;374:451-8. [PMID: 19643469]
12. Siston AM, Rasmussen SA, Honein MA, Fry AM, Seib K, Callaghan WM, et al; Pandemic H1N1 Influenza in Pregnancy Working Group. Pandemic 2009 influenza A(H1N1) virus illness among pregnant women in the United States. JAMA. 2010;303:1517-25. [PMID: 20407061]
13. World Health Organization. Availability of a Candidate Reassortant Vaccine Virus for the Novel Influenza A (H1N1) Vaccine Development. Geneva: World Health Organization; 2009. Accessed at www.who.int/csr/resources/publications/swineflu/candidates_X-179a/en/index.html on 6 October 2011
14. Kendal AP, Pereira MS, Skehel JJ, eds. Concepts and Procedures for Laboratory-Based Influenza Surveillance. Atlanta, GA: Centers for Disease Control and Prevention; 1982
15. U.S. Food and Drug Administration. International Conference on Harmonisation; Guideline on the Validation of Analytical Procedures: Methodology; Availability. Fed Regist. 1997;62:27464
16. Committee for Proprietary Medicinal Products. Note for Guidance on Harmonization of Requirements for Influenza Vaccines. London: European Medicines Agency; 1997. Accessed at www.emea.europa.eu/pdfs/human/bwp /021496en.pdf on 6 October 2011
17. Committee for Medicinal Products for Human Use. Guideline on Dossier Structure and Content for Pandemic Influenza Vaccine Marketing Authorization Application. London: European Medicines Agency; 2004
18. Committee for Human Medicinal Products. Guideline on Influenza Vaccine Prepared From Viruses With the Potential to Cause a Pandemic and Intended for Use Outside of the Core Dossier Context. London: European Medicines Agency; 2007
19. Center for Biologics Evaluation and Research. Guidance for Industry: Clinical Data Needed to Support the Licensure of Pandemic Influenza Vaccines. Silver Spring, MD: U.S. Food and Drug Administration; 2007. Accessed at www.fda.gov/cber/gdlns/panfluvac.htm on 6 October 2011
20. Bland JM, Altman DG. Transformations, means, and confidence intervals. BMJ. 1996;312:1079. [PMID: 8616417]
21. Plennevaux E, Sheldon E, Blatter M, Reeves-Hoché MK, Denis M. Immune response after a single vaccination against 2009 influenza A H1N1 in USA: a preliminary report of two randomised controlled phase 2 trials. Lancet. 2010; 375:41-8. [PMID: 20018365]
22. Hobson D, Curry RL, Beare AS, Ward-Gardner A. The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B viruses. J Hyg (Lond). 1972;70:767-77. [PMID: 4509641]
23. Coudeville L, Andre P, Bailleux F, Weber F, Plotkin S. A new approach to estimate vaccine efficacy based on immunogenicity data applied to influenza vaccines administered by the intradermal or intramuscular routes. Hum Vaccin. 2010;6:841-8. [PMID: 20930559]
24. Initial results show pregnant women mount strong immune response to one dose of 2009 H1N1 flu vaccine [news release]. Bethesda, MD: National Institutes of Health; 2 November 2009. Accessed at www.nih.gov/news/health /nov2009/niaid-02.htm on 6 October 2011
25. Ohfuji S, Fukushima W, Deguchi M, Kawabata K, Yoshida H, Hatayama H, et al. Immunogenicity of a monovalent 2009 influenza A (H1N1) vaccine among pregnant women: lowered antibody response by prior seasonal vaccination. J Infect Dis. 2011;203:1301-8. [PMID: 21459817]
26. Englund JA. The influence of maternal immunization on infant immune responses. J Comp Pathol. 2007;137 Suppl 1:S16-9. [PMID: 17553516]
27. Roopenian DC, Akilesh S. FcRn: the neonatal Fc receptor comes of age. Nat Rev Immunol. 2007;7:715-25. [PMID: 17703228]
28. Pentsuk N, van der Laan JW. An interspecies comparison of placental antibody transfer: new insights into developmental toxicity testi ng of monoclonal antibodies. Birth Defects Res B Dev Reprod Toxicol. 2009;86:328-44. [PMID: 19626656]
29. Zuccotti G, Pogliani L, Pariani E, Amendola A, Zanetti A. Transplacental antibody transfer following maternal immunization with a pandemic 2009 influenza A(H1N1) MF59-adjuvanted vaccine. JAMA. 2010;304:2360-1. [PMID: 21119083]
30. Steinhoff MC, Omer SB, Roy E, Arifeen SE, Raqib R, Altaye M, et al. Influenza immunization in pregnancy-antibody responses in mothers and infants [Letter]. N Engl J Med. 2010;362:1644-6. [PMID: 20427817]
31. Lacroix I, Damase-Michel C, Kreft-Jais C, Castot A, Montastruc JL; French Association of Regional Pharmacovigilance Centres. 2009 H1N1 influenza vaccines in pregnant women: the French Pharmacovigilance survey [Letter]. Vaccine. 2011;29:1357-8. [PMID: 21185422]